KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Cash from Financing Activities (2016 - 2025)

Historic Cash from Financing Activities for Globus Medical (GMED) over the last 15 years, with Q3 2025 value amounting to -$32.0 million.

  • Globus Medical's Cash from Financing Activities fell 26362.15% to -$32.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$632.6 million, marking a year-over-year decrease of 9483.95%. This contributed to the annual value of -$27.7 million for FY2024, which is 8805.29% up from last year.
  • According to the latest figures from Q3 2025, Globus Medical's Cash from Financing Activities is -$32.0 million, which was down 26362.15% from -$24.9 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Cash from Financing Activities registered a high of $59.7 million during Q4 2024, and its lowest value of -$635.4 million during Q1 2025.
  • Its 5-year average for Cash from Financing Activities is -$53.0 million, with a median of $2.9 million in 2023.
  • Its Cash from Financing Activities has fluctuated over the past 5 years, first skyrocketed by 142854.35% in 2022, then tumbled by 403608.84% in 2024.
  • Quarter analysis of 5 years shows Globus Medical's Cash from Financing Activities stood at -$1.0 million in 2021, then surged by 1428.54% to $13.6 million in 2022, then tumbled by 1845.79% to -$237.3 million in 2023, then skyrocketed by 125.18% to $59.7 million in 2024, then crashed by 153.64% to -$32.0 million in 2025.
  • Its Cash from Financing Activities stands at -$32.0 million for Q3 2025, versus -$24.9 million for Q2 2025 and -$635.4 million for Q1 2025.